Clearstead Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60
| Closed | -$636 | – | 2734 |
|
|
2025
Q1 | $636 | Hold |
60
| – | – | ﹤0.01% | 2039 |
|
|
2024
Q4 | $1.02K | Buy |
60
+40
| +200% | +$679 | ﹤0.01% | 1913 |
|
|
2024
Q3 | $465 | Hold |
20
| – | – | ﹤0.01% | 1954 |
|
|
2024
Q2 | $487 | Hold |
20
| – | – | ﹤0.01% | 1938 |
|
|
2024
Q1 | $575 | Hold |
20
| – | – | ﹤0.01% | 1444 |
|
|
2023
Q4 | $631 | Sell |
20
-20
| -50% | -$631 | ﹤0.01% | 1441 |
|
|
2023
Q3 | $1.02K | Buy |
40
+20
| +100% | +$511 | ﹤0.01% | 1455 |
|
|
2023
Q2 | $574 | Hold |
20
| – | – | ﹤0.01% | 1291 |
|
|
2023
Q1 | $480 | Hold |
20
| – | – | ﹤0.01% | 1306 |
|
|
2022
Q4 | $339 | Hold |
20
| – | – | ﹤0.01% | 1255 |
|
|
2022
Q3 | $0 | Hold |
20
| – | – | ﹤0.01% | 1241 |
|
|
2022
Q2 | $0 | Hold |
20
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q1 | $1K | Hold |
20
| – | – | ﹤0.01% | 1261 |
|
|
2021
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 1151 |
|
|
2021
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 1175 |
|
|
2021
Q2 | $1K | Buy |
+20
| New | +$1K | ﹤0.01% | 1120 |
|